- Home
- SERA vs VTGN Comparison
SERA vs VTGN Comparison
Compare SERA & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- VTGN
- Stock Information
- Founded
- SERA 2008
- VTGN 1998
- Country
- SERA United States
- VTGN United States
- Employees
- SERA N/A
- VTGN N/A
- Industry
- SERA Precision Instruments
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- SERA Health Care
- VTGN Health Care
- Exchange
- SERA Nasdaq
- VTGN Nasdaq
- Market Cap
- SERA 90.6M
- VTGN 87.2M
- IPO Year
- SERA 2021
- VTGN N/A
- Fundamental
- Price
- SERA $3.25
- VTGN $3.65
- Analyst Decision
- SERA
- VTGN
- Analyst Count
- SERA 0
- VTGN 0
- Target Price
- SERA N/A
- VTGN N/A
- AVG Volume (30 Days)
- SERA 64.5K
- VTGN 531.7K
- Earning Date
- SERA 11-05-2025
- VTGN 11-06-2025
- Dividend Yield
- SERA N/A
- VTGN N/A
- EPS Growth
- SERA N/A
- VTGN N/A
- EPS
- SERA N/A
- VTGN N/A
- Revenue
- SERA $108,000.00
- VTGN $646,000.00
- Revenue This Year
- SERA $217.92
- VTGN $10.19
- Revenue Next Year
- SERA $479.25
- VTGN $705.79
- P/E Ratio
- SERA N/A
- VTGN N/A
- Revenue Growth
- SERA 0.94
- VTGN N/A
- 52 Week Low
- SERA $1.37
- VTGN $1.90
- 52 Week High
- SERA $9.13
- VTGN $3.88
- Technical
- Relative Strength Index (RSI)
- SERA 58.22
- VTGN 62.23
- Support Level
- SERA $2.87
- VTGN $3.44
- Resistance Level
- SERA $3.12
- VTGN $3.75
- Average True Range (ATR)
- SERA 0.23
- VTGN 0.23
- MACD
- SERA -0.02
- VTGN 0.02
- Stochastic Oscillator
- SERA 63.77
- VTGN 89.01
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.